01

We discovered that the most frequent pregnancy-specific disease, pre-eclampsia, can be alleviated by targeting of mechano-sensitive AT1-B2 receptor heterodimers. Our landmark discovery has been published in "Cell" (Vol. 176, pp. 318-333, 2019)